Quattro A6 A4 Quattro A4 For A6 New Support Lift Lid Trunk S6 S4 RS4 Other Car & Truck Exterior Parts


  1. Home
  2. Quattro A6 A4 Quattro A4 For A6 New Support Lift Lid Trunk S6 S4 RS4
  1. facebook
  2. twitter
  3. linkedin
  4. pinterest
For A4 Quattro A4 A6 Quattro A6 RS4 S4 S6 Trunk Lid Lift Support New
Condition: New Brand:

WD Express

Warranty: 2 Year Manufacturer Part Number:

926 54073 316

Fitment Type: Direct Replacement MPN:

926 54073 316

Superseded Part Number: 8104232, 29429, 614003, SG401042 Interchange Part Number: 8E5827552J
Part Brand: OE Aftermarket Other Part Number: 92654073738
UPC:

Does Not Apply

published on tue nov 09 2021

Quattro A6 A4 Quattro A4 For A6 New Support Lift Lid Trunk S6 S4 RS4 Other Car & Truck Exterior Parts

gandhi, s., klein, j., robertson, a., pena-hernandez, m. a.,

Quattro A6 A4 Quattro A4 For A6 New Support Lift Lid Trunk S6 S4 RS4 Other Car & Truck Exterior Parts

lin, m. j., roychoudhury, p., lu, p., fournier, j., ferguson, d., mohamed bakhash, s. a., muenker, m. c., srivathsan, a., wunder, e. a., kerantzas, n., wang, w., pyle, a., wilen, c. b., ogbuagu, o., greninger ,, a. l., iwasaki, a., schulz, w. l., ko, a. i.

sars-cov-2 remdesivir resistance mutations have been generated in vitro but have not been reported in patients receiving treatment with the antiviral agent. we present a case of an immunocompromised patient with acquired b-cell deficiency who developed an indolent, protracted course of sars-cov-2 infection. remdesivir therapy alleviated symptoms and produced a transient virologic response, but her course was complicated by recrudescence of high-grade viral shedding. whole genome sequencing identified a mutation, e802d, in the nsp12 rna-dependent rna polymerase which was not present in pre-treatment specimens. in vitro experiments demonstrated that the mutation conferred a ~6-fold increase in remdesivir ic50 but resulted in a fitness cost in the absence of remdesivir. sustained clinical and virologic response was achieved after treatment with casirivimab-imdevimab. although the fitness cost observed in vitro may limit the risk posed by e802d,

, this case illustrates the importance of monitoring for remdesivir resistance and the potential benefit of combinatorial therapies in immunocompromised patients with sars-cov-2 infection.

509
1.2k
EVGENIA.RU RSS